BCL2 and malignant colon neoplasm: The team used HCT AKO, a human colon cancer epithelial cell line deprived of all essential proapoptotic and antiapoptotic Bcl-2 family members, including Bcl-2, Bcl-xL, Bid, Bax, and Bak, through gene knockout.